180 related articles for article (PubMed ID: 29223376)
1. Optical Coherence Tomography of Magnesium Bioresorbable Scaffold Restenosis.
García-Blas S; Miñana G; Sanchis J
Rev Esp Cardiol (Engl Ed); 2018 Dec; 71(12):1069. PubMed ID: 29223376
[No Abstract] [Full Text] [Related]
2. Impact of post-dilatation on strut apposition of second-generation bioresorbable vascular scaffolds: Key role for scaffold thrombosis and prognosis?
Frangieh AH; Jaguszewski M; Imori Y; Obeid S; Templin C
Cardiol J; 2018; 25(1):148-150. PubMed ID: 29512102
[No Abstract] [Full Text] [Related]
3. Use of a bioresorbable novolimus eluting vascular scaffold fails a hybrid PCI strategy with drug eluting stent.
Schneider VS; Skurk C; Riedel M; Abdelwahed YS; Landmesser U; Leistner DM
Clin Res Cardiol; 2017 Jul; 106(7):557-559. PubMed ID: 28374059
[No Abstract] [Full Text] [Related]
4. Treading the risky ground of coronary bifurcation lesion revascularization, the "biodegradable strategy" may represent the lifeline.
Piraino D; Buccheri D; Andolina G
Int J Cardiol; 2016 Oct; 221():577-80. PubMed ID: 27420582
[No Abstract] [Full Text] [Related]
5. Late neoatherosclerotic scaffold failure: An unexpected achilles heel for current bioresorbable scaffold technology?
Hiltrop N; Jorge C; Bennett J; Adriaenssens T
Int J Cardiol; 2016 Nov; 223():133-135. PubMed ID: 27537739
[No Abstract] [Full Text] [Related]
6. Bioresorbable vascular scaffolds: implication of very late scaffold thrombosis.
Mori H; Virmani R; Finn AV
Coron Artery Dis; 2017 Nov; 28(7):533-538. PubMed ID: 28692483
[No Abstract] [Full Text] [Related]
7. Neointimal proliferation is associated with clinical restenosis 2 years after fully bioresorbable vascular scaffold implantation.
Indolfi C; Mongiardo A; Spaccarotella C; Caiazzo G; Torella D; De Rosa S
Circ Cardiovasc Imaging; 2014 Jul; 7(4):755-7. PubMed ID: 25027457
[No Abstract] [Full Text] [Related]
8. Restenosis of Coronary Bioresorbable Vascular Scaffolds.
Alfonso F; García-Guimaraes M
Rev Esp Cardiol (Engl Ed); 2017 Jul; 70(7):527-531. PubMed ID: 28285939
[No Abstract] [Full Text] [Related]
9. Real-World Bioresorbable Vascular Scaffold Experience Compared With Second-Generation Metallic Drug-Eluting Stents in Complex Coronary Lesions.
Okamoto N; Ueda H; Yoshimura T; Chamaria S; Bhatheja S; Vengrenyuk Y; Rabiei S; Barrientos Y; Kapur V; Barman N; Sweeny J; Baber U; Mehran R; Sharma SK; Kini AS
J Invasive Cardiol; 2018 Jul; 30(7):251-255. PubMed ID: 29656280
[TBL] [Abstract][Full Text] [Related]
10. Bioresorbable vascular scaffolds in coronary bifurcation lesions: The next frontiers?
Leesar MA
Catheter Cardiovasc Interv; 2016 Nov; 88(6):870-871. PubMed ID: 27886452
[No Abstract] [Full Text] [Related]
11. Bioresorbable Vascular Scaffold Thrombosis: Clinical and Optical Coherence Tomography Findings.
Cuesta J; García-Guimaraes M; Basante T; Rivero F; Antuña P; Alfonso F
Rev Esp Cardiol (Engl Ed); 2019 Jan; 72(1):90-91. PubMed ID: 29223378
[No Abstract] [Full Text] [Related]
12. Coronary artery perforation at the level of two-overlapping bioresorbable vascular scaffolds: The importance of vessel sizing and scaffold thickness.
Pichette M; Chevalier F; Généreux P
Catheter Cardiovasc Interv; 2015 Oct; 86(4):686-91. PubMed ID: 26122768
[TBL] [Abstract][Full Text] [Related]
13. Bioresorbable vascular scaffold strut disruption after crossing with an optical coherence tomography imaging catheter.
Sato K; Panoulas VF; Naganuma T; Miyazaki T; Latib A; Colombo A
Int J Cardiol; 2014 Jul; 174(3):e116-9. PubMed ID: 24814543
[No Abstract] [Full Text] [Related]
14. Computed tomography angiography for guiding and follow-up of magnesium-bioresorbable scaffold implantation.
Opolski MP; Kepka C; Wojakowski W; Witkowski A
Clin Res Cardiol; 2019 Mar; 108(3):344-346. PubMed ID: 30182164
[No Abstract] [Full Text] [Related]
15. Follow-up evaluation of unapposed bioresorbable vascular scaffold at a coronary bifurcation using optical coherence tomography.
Danson E; Bhindi R; Hansen P
Int J Cardiol; 2014 Dec; 177(2):e84-6. PubMed ID: 25456696
[No Abstract] [Full Text] [Related]
16. Intraluminal bioresorbable vascular scaffold dismantling with aneurysm formation leading to very late thrombosis.
Patel A; Nazif T; Stone GW; Ali ZA
Catheter Cardiovasc Interv; 2017 Apr; 89(5):876-879. PubMed ID: 28145045
[TBL] [Abstract][Full Text] [Related]
17. [Coronary stents: what is new?].
Zeus T; Münzel T
Dtsch Med Wochenschr; 2014 Apr; 139(14):701-3. PubMed ID: 24668429
[No Abstract] [Full Text] [Related]
18. Comparison of acute expansion of bioresorbable vascular scaffolds versus metallic drug-eluting stents in different degrees of calcification: An Optical Coherence Tomography Study.
Ming Fam J; van Der Sijde JN; Karanasos A; Felix C; Diletti R; van Mieghem N; de Jaegere P; Zijlstra F; Jan van Geuns R; Regar E
Catheter Cardiovasc Interv; 2017 Apr; 89(5):798-810. PubMed ID: 27717119
[TBL] [Abstract][Full Text] [Related]
19. The Absorb Limits.
Gómez Menchero AE; Camacho Freire SJ; Díaz Fernández JF; Roa Garrido J; León Jiménez J; Cardenal Piris R
J Invasive Cardiol; 2016 Oct; 28(10):E122-E123. PubMed ID: 27705895
[TBL] [Abstract][Full Text] [Related]
20. A Case of Single Coronary With Very Late In-Stent Restenosis of Drug-Eluting Stents After 12 Years.
Vijayvergiya R; Kumar B; Budhakoty S; Kasinadhuni G; Kanabar K
J Invasive Cardiol; 2019 Nov; 31(11):E333-E334. PubMed ID: 31671063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
